Founders Financial Securities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
2,832
-25
| -0.9% | -$3.03K | 0.03% | 396 |
|
|
2025
Q1 | $322K | Buy |
2,857
+87
| +3% | +$9.8K | 0.03% | 384 |
|
|
2024
Q4 | $270K | Sell |
2,770
-50
| -2% | -$4.87K | 0.02% | 394 |
|
|
2024
Q3 | $324K | Sell |
2,820
-12
| -0.4% | -$1.38K | 0.03% | 344 |
|
|
2024
Q2 | $301K | Buy |
2,832
+94
| +3% | +$10K | 0.03% | 347 |
|
|
2024
Q1 | $265K | Buy |
2,738
+318
| +13% | +$30.8K | 0.03% | 335 |
|
|
2023
Q4 | $244K | Sell |
2,420
-109
| -4% | -$11K | 0.03% | 329 |
|
|
2023
Q3 | $258K | Hold |
2,529
| – | – | 0.03% | 290 |
|
|
2023
Q2 | $255K | Buy |
2,529
+300
| +13% | +$30.3K | 0.03% | 278 |
|
|
2023
Q1 | $205K | Hold |
2,229
| – | – | 0.03% | 298 |
|
|
2022
Q4 | $202K | Buy |
+2,229
| New | +$202K | 0.03% | 306 |
|
|
2022
Q3 | – | Sell |
-2,491
| Closed | -$211K | – | 311 |
|
|
2022
Q2 | $211K | Hold |
2,491
| – | – | 0.04% | 240 |
|
|
2022
Q1 | $219K | Buy |
+2,491
| New | +$219K | 0.04% | 246 |
|
|
2021
Q3 | – | Sell |
-2,217
| Closed | -$202K | – | 284 |
|
|
2021
Q2 | $202K | Buy |
+2,217
| New | +$202K | 0.04% | 283 |
|
|
2018
Q4 | – | Sell |
-11,303
| Closed | -$873K | – | 112 |
|
|
2018
Q3 | $873K | Buy |
11,303
+94
| +0.8% | +$7.26K | 0.24% | 57 |
|
|
2018
Q2 | $759K | Sell |
11,209
-25
| -0.2% | -$1.69K | 0.23% | 58 |
|
|
2018
Q1 | $814K | Buy |
11,234
+250
| +2% | +$18.1K | 0.26% | 59 |
|
|
2017
Q4 | $826K | Buy |
10,984
+198
| +2% | +$14.9K | 0.27% | 55 |
|
|
2017
Q3 | $830K | Buy |
10,786
+454
| +4% | +$34.9K | 0.3% | 51 |
|
|
2017
Q2 | $773K | Buy |
+10,332
| New | +$773K | 0.29% | 52 |
|